Financhill
Buy
52

CYCN Quote, Financials, Valuation and Earnings

Last price:
$3.24
Seasonality move :
-0.35%
Day range:
$2.83 - $3.43
52-week range:
$1.27 - $9.47
Dividend yield:
0%
P/E ratio:
3.20x
P/S ratio:
--
P/B ratio:
1.05x
Volume:
262.9K
Avg. volume:
6.5M
1-year change:
-24.94%
Market cap:
$8.6M
Revenue:
--
EPS (TTM):
-$2.14

Earnings Data

Next earnings date for CYCN
May 07
2025
Most recent earnings per share
-$0.29
Missed by $0.29
(Nov 14/2024)
Consensus Estimate
--
(Nov 14/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

CYCN Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
11/14/2024 Q3 -- $194K -$0.29 -- --
08/07/2024 Q2 -- -- -$0.53 -- --
05/07/2024 Q1 -- -- -$0.62 -- --
03/22/2024 Q4 -- -- -$0.70 -- --
11/13/2023 Q3 -- -- $2.72 -- --
06/30/2023 Q2 -- -- -$1.83 -- --
03/31/2023 Q1 -- -- -$3.20 -- --
12/31/2022 Q4 -- -- -$3.32 -- --
11/09/2022 Q3 -- -- -$4.83 -$7.00 $2.17
08/09/2022 Q2 -- -- -$6.16 -$6.80 $0.64
05/04/2022 Q1 -- -- -$6.00 -$7.20 $1.20
02/25/2022 Q4 -- -- -$4.80 -$6.40 $1.60
11/09/2021 Q3 -- -- -$5.20 -$5.80 $0.60
07/29/2021 Q2 -- -- -$9.00 -- --
04/30/2021 Q1 -- -- -$7.80 -- --
02/25/2021 Q4 -- -- -$11.00 -$3.80 -$7.20
11/05/2020 Q3 -- -- -$11.80 -- --
08/03/2020 Q2 -- -- -$14.00 -- --
05/04/2020 Q1 -- -- -$14.60 -- --
03/12/2020 Q4 -- -- -$19.00 -- --
11/12/2019 Q3 -- -- -$20.00 -- --
08/12/2019 Q2 -- -- -$23.60 -- --
05/13/2019 Q1 -- -- -$27.40 -- --
12/31/2018 Q4 -- -- -$22.64 -- --
09/30/2018 Q3 -- -- -$21.45 -- --
06/30/2018 Q2 -- -- -$21.81 -- --
03/31/2018 Q1 -- -- -$18.52 -- --

Cyclerion Therapeutics Earnings Questions

  • How Much did Cyclerion Therapeutics Generate in Revenue Last Quarter?

    Cyclerion Therapeutics reported $194K worth of top line sales in its most recent quarter.

  • Did Cyclerion Therapeutics Beat Earnings Last Quarter?

    Cyclerion Therapeutics announced earnings per share of -$0.29 which represents a miss of analyst forecast a -- per share.

  • Is Cyclerion Therapeutics Profitable?

    Cyclerion Therapeutics reported -- that represents -- per share over the last quarter.

  • What is the Analyst Consensus for Cyclerion Therapeutics EPS Next Year?

    Cyclerion Therapeutics's earnings are forecast to grow from -$2.25 per share to -- per share next year representing an increase of --.

  • When is Cyclerion Therapeutics's Earnings Date?

    Cyclerion Therapeutics's next earnings date is May 7, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Will Tyson Foods Stock Bounce Back?
Will Tyson Foods Stock Bounce Back?

Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…

Will Iovance Biotherapeutics Stock Bounce Back?
Will Iovance Biotherapeutics Stock Bounce Back?

Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…

Stock Ideas

Buy
64
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 42x

Buy
52
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 113x

Buy
55
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Buy
61
QMCO alert for Dec 21

Quantum [QMCO] is up 26.28% over the past day.

Sell
46
NUKK alert for Dec 21

Nukkleus [NUKK] is down 22.94% over the past day.

Sell
1
IIPR alert for Dec 21

Innovative Industrial Properties [IIPR] is down 22.7% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock